To further understand the molecular mechanisms underlying ETBO-induced apoptosis, western blotting was performed to investigate the expression levels of apoptotic markers Bcl-2, caspase-3, and p53 in human cancer and normal cells in response to ETBO treatment for 24 h. This evidence concerns the gene TP53 and cancer.